Chenghe Acquisition III Co. (CHEC)

Chenghe Acquisition III Co. (CHEC) is a special-purpose-acquisition-company in pre-merger form—essentially a cash shell created to acquire an operating business. Investors face acute risks: sponsor conflicts of interest, the unknown identity and quality of any future target, dilution from SPAC sponsor fees, and the possibility that no acceptable acquisition is completed before the company is forced to liquidate and return cash.

The Core SPAC Structure Problem

SPAC investors confront an uncomfortable reality: they own a company with no disclosed business, no revenue, no employees, and no products. The only asset is cash from the IPO, and the only obligation is to identify and acquire an operating business. The investor must trust that the SPAC’s sponsors (the promoters who organized the shell company) will find a decent target, that the deal will be fair, and that post-merger, the combined company will create shareholder value.

This is a structural conflict of interest. SPAC sponsors earn a commission (typically 20% of the capital raised) if and only if a merger completes. They have zero incentive to be picky about targets—they earn the same fee whether the deal is brilliant or mediocre. This creates a race to complete any acceptable deal, not to find the best deal. In practice, it means SPAC investors often end up with overpriced, struggling, or second-tier operating companies that would never have attracted capital in a traditional IPO.

Dilution and Fee Extraction

SPAC sponsors retain founder shares (typically 20% of the company) at minimal cost. When the company goes public, those sponsor shares become valuable, but they remain completely diluted with no effort from sponsors. Additionally, sponsors extract fees for “advisory services” during the acquisition search. These fees—often millions of dollars—come from the cash raised from public shareholders. After all fees and sponsor dilution, public shareholders are left with less equity value than their cash contribution warrants.

Chenghe, like all SPACs, extracted sponsor fees and founder profits from the pool of capital that public investors contributed. The earnings and balance-sheet of any future operating company will be substantially impaired by the cost basis of the SPAC acquisition structure.

Unknown Merger Target and Duration Risk

Until Chenghe announces a target, investors have no way to assess deal quality. Will the merger partner be a solid, profitable company, or a venture-backed money-loser that could not raise institutional funding at a reasonable valuation? Will the target’s industry be cyclical or stable? Will it have technological risk, regulatory risk, or concentration risk? No one knows. SPAC investors are, by definition, investing blindly.

Additionally, SPACs face time pressure. The company typically has 18–24 months to announce and complete a merger or face liquidation. This deadline creates incentives to rush rather than deliberate. If Chenghe’s leadership senses that no truly compelling target is available, they may still force a mediocre deal rather than face the embarrassment of liquidation and return of capital.

Voting and Redemption Dynamics

Before a merger votes, SPAC shareholders have the right to redeem their shares and receive a pro-rata share of the cash held in trust. This mechanics means that if a merger is announced and a meaningful portion of shareholders object, they will redeem, leaving less cash for the business combination than was originally raised. This happened frequently in the 2020-2021 SPAC boom—shareholders redeemed, target companies received far less capital than expected, and post-merger valuations deflated rapidly.

Chenghe will face the same dynamic. If sponsors announce a questionable target, redemptions could be high, and the company will either need to find additional financing or reduce the acquisition price.

Post-Merger Company Risk

Assuming Chenghe successfully merges with an operating company, the biggest risk is execution. SPAC mergers often pair sponsors with limited operating experience with acquisition targets that lack institutional rigor. Integration is messy, management teams clash, and the post-merger entity underperforms projections. This is not a statistical quirk—it is a repeating pattern across SPAC acquisitions. The combined company will be unloved by momentum investors (who exit once the merger closes) and unloved by fundamental investors (who see a company with uncertain prospects, diluted cap structure, and unproven management).

Warrant Overhang

SPACs issue warrants (options to buy shares at a fixed price) as part of the IPO. These warrants are economically valuable, and when the stock price exceeds the warrant strike price, warrant holders exercise and dilute ordinary shareholders. Chenghe will face this dilution if its post-merger stock price rises materially. The warrant overhang is rarely mentioned in SPAC marketing materials, but it is a real claim on future shareholder value.

Information Asymmetry

SPAC sponsors and the investment banks managing the IPO have strong incentives to oversell the SPAC as an investment vehicle. They know the target company is not yet identified and the merger is speculative, but marketing materials often use vague language about “opportunities in [sector]” to imply that management has a specific target in mind. In reality, they often do not—the target is identified during the investor road show and finalized months after IPO. Chenghe’s offering documents will make clear that this is a blind-pool investment, but many retail investors do not read or understand that distinction.

Valuation and Downside Risk

SPAC shares are typically offered at $10, and SPACs trade near that level before a merger is announced. Once a target is identified, the stock price can swing wildly depending on whether the market views the deal as cheap (stock up) or expensive (stock down). The realistic downside is significant: if the merger target is mediocre or the post-merger company stumbles, shares can fall 50% or more within a year, particularly if redemptions or warrant dilution force a recapitalization.

The Skeptic’s Position

SPAC structures were created to enable faster capital access for private companies without the discipline of traditional IPO underwriting. The result is a vehicle that systematically favors sponsors and insiders at the expense of public shareholders. Chenghe, like all SPACs, is a bet on the sponsors’ judgment and deal-making ability. If you believe Chenghe’s sponsors have identified (but not yet disclosed) a compelling target, and if you believe they will prioritize shareholder returns over fee extraction, the risk is lower. If not, Chenghe is a speculative bet on an unknown company with a diluted cap structure—not a public-company investment in the traditional sense.

The 10-K and any merger proxy will eventually disclose the target’s financials and terms. At that point, investors will have a real decision to make. Until then, owning Chenghe is betting on the competence of its sponsors and management, nothing more.